Design and in vitro characterization of buccoadhesive tablets of timolol maleate
- PMID: 24592893
- DOI: 10.3109/03639045.2014.892955
Design and in vitro characterization of buccoadhesive tablets of timolol maleate
Abstract
Objective: The purpose of this work was to develop and evaluate buccoadhesive tablets of timolol maleate (TM) due to its potential to circumvent the first-pass metabolism and to improve its bioavailability.
Methods: The tablets were prepared by direct compression using two release modifying polymers, Carbopol 974P (Cp-974p) and sodium alginate (SA). A 3(2) full factorial design was employed to study the effect of independent variables, Cp-974p and SA, in various proportions in percent w/w, which influences the in vitro drug release and bioadhesive strengths. Physicochemical properties of the drug were evaluated by ultraviolet, Fourier transform infrared spectroscopy (FTIR), differential scanning calorimetry (DSC) and powder X-ray diffraction (P-XRD). Tablets were evaluated for hardness, thickness, weight variation, drug content, surface pH, swelling index, bioadhesive force and in vitro drug release.
Results: The FTIR and DSC studies showed no evidence of interactions between drug, polymers and excipients. The P-XRD study revealed that crystallinity of TM remain unchanged in optimized formulation tablet. Formulation F9 achieves an in vitro drug release of 98.967% ± 0.28 at 8 h and a bioadhesive force of 0.088 N ± 0.01211.
Conclusion: We successfully developed buccal tablet formulations of TM and describe a non-Fickian-type anomalous transport as the release mechanism.
Similar articles
-
Once daily bioadhesive vaginal clotrimazole tablets: design and evaluation.Acta Pharm. 2006 Sep;56(3):337-45. Acta Pharm. 2006. PMID: 19831282
-
Preparation and in vitro/in vivo evaluation of the buccal bioadhesive properties of slow-release tablets containing miconazole nitrate.Drug Dev Ind Pharm. 2003 Mar;29(3):321-37. doi: 10.1081/ddc-120018206. Drug Dev Ind Pharm. 2003. PMID: 12741613
-
Formulation, development and in vitro characterization of modified release tablets of capecitabine.Drug Dev Ind Pharm. 2020 Jan;46(1):20-30. doi: 10.1080/03639045.2019.1698595. Epub 2019 Dec 6. Drug Dev Ind Pharm. 2020. PMID: 31778085
-
Development and evaluation of pH-sensitive sodium alginate/chitosan microparticles containing the antituberculosis drug rifampicin.Mater Sci Eng C Mater Biol Appl. 2014 Jun 1;39:161-7. doi: 10.1016/j.msec.2014.01.054. Epub 2014 Feb 10. Mater Sci Eng C Mater Biol Appl. 2014. PMID: 24863212 Review.
-
Principle and investigation of the bioadhesion mechanism of solid dosage forms.Biomaterials. 1992;13(10):709-14. doi: 10.1016/0142-9612(92)90132-8. Biomaterials. 1992. PMID: 1420717 Review.
Cited by
-
A novel fixed-combination timolol-netarsudil-latanoprost ophthalmic solution for the treatment of glaucoma and ocular hypertension.Asian J Pharm Sci. 2022 Nov;17(6):938-948. doi: 10.1016/j.ajps.2022.11.001. Epub 2022 Nov 17. Asian J Pharm Sci. 2022. PMID: 36600899 Free PMC article.
-
Application of Tablet in Tablet technique to design and characterize immediate and modified release tablets of Timolol maleate.Heliyon. 2024 Feb 3;10(3):e25820. doi: 10.1016/j.heliyon.2024.e25820. eCollection 2024 Feb 15. Heliyon. 2024. PMID: 38356537 Free PMC article.
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Miscellaneous